Intelligent Market Cap from 2010 to 2025

INBS Stock  USD 1.39  0.08  6.11%   
Intelligent Bio Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap will likely drop to about 3.2 M in 2025. From the period from 2010 to 2025, Intelligent Bio Market Cap quarterly data regression had r-value of (0.88) and coefficient of variation of  81.97. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
3.4 M
Current Value
3.2 M
Quarterly Volatility
446.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 1.02, Dividend Yield of 0.0 or PTB Ratio of 0.33. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Market Cap Growth Pattern

Below is the plot of the Market Cap of Intelligent Bio Solutions over the last few years. It is Intelligent Bio's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Intelligent Market Cap Regression Statistics

Arithmetic Mean544,370,160
Geometric Mean175,524,467
Coefficient Of Variation81.97
Mean Deviation427,247,799
Median924,145,981
Standard Deviation446,235,512
Sample Variance199126.1T
Range921.2M
R-Value(0.88)
Mean Square Error48361.6T
R-Squared0.77
Slope(82,423,401)
Total Sum of Squares2986892T

Intelligent Market Cap History

20253.2 M
20243.4 M
20232.9 M
202233.5 M
2019116.5 M

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Market Cap, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap3.4 M3.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.